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Reply to the Editor." 
I would like to respond to the issues addressed to me 
by Dr. Chanda concerning extent of glutaraldehyde 
fixation and calcification of bioprosthetic tissue. Our 
hydrothermal isometric temperature or denaturation 
temperature data indicate that dynamic fixation stabi- 
lized porcine aortic heart valve tissue within 3 hours 15 
minutes and 24 hours when the tissue was fixed at room 
temperature in 0.5% and 0.05% glutaraldehyde, r spec- 
tively. Previous authors have suggested that at concen- 
trations from 0.625% down to 0.025%, glutaraldehyde 
cross-linking is rapid and the degree of cross-linking 
reaches a plateau within 24 hours, consistent with our 
study. 1-4 In contrast, Chachques and associates 5 sug- 
gested that adequate fixation of pericardium could be 
achieved with a brief 10-minute immersion in standard 
glutaraldehyde solution (0.625%). Complete saturation 
remains elusive. Schoen, Tsao, and Levy 2 have shown 
that only 70% of the reactive sites of collagen react. 
This is due to limitations in the accessibility of the 
reactive sites and also resistance to diffusion of the 
glutaraldehyde reagent, a problem likely caused by 
glutaraldehyde polymer film formation (e.g., steric hin- 
derance factors). 6'7 We believe some of these limita- 
tions may be overcome by means of our dynamic 
fixation technique. The gradual depletion of glutaral- 
dehyde in the preservative solution during long periods 
(exceeding 4 to 8 weeks) is less likely caused by 
completion of saturation than by rapid incorporation of 
glutaraldehyde monomers recruited during polymer 
formation. Polymer growth (i.e., alpha- or beta-unsat- 
urated aldehyde polymers) can be catalyzed by amino 
acids (e.g., lysine, hydroxylysine), the rate of growth 
increasing rapidly with time and exponentially with 
temperature and pH. 3,s Thus the observation, by 
Chanda and associates, that shorter periods of time are 
required to achieve complete saturation at higher tem- 
peratures (i.e., more than 8 weeks at 4 ° or 10 ° C and less 
than 4 weeks at 37 ° C) is consistent with the hypothesis 
of glutaraldehyde consumption by polymer formation. 
The fact that glutaraldehyde incorporation finally 
reaches a limit in their study (i.e., after more than 8 
weeks at 0.25%) may be associated with simple limita- 
tions in the extent of glutaraldehyde polymer growth. 
With respect o glutaraldehyde-mediated calcification, 
although the mechanism is yet unclear, ample evidence 
indicates a direct relationship between the extent of tissue 
calcification and the amounts of glutaraldehyde used or 
incorporated during tissue fixation, 1' 2, 9, lo along with the 
duration of tissue exposure to the glutaraldehyde solu- 
tion. a~ 
Thus the use of a technique (e.g., dynamic fixation) that 
can both reduce glutaraldehyde levels and concomitantly 
achieve similar or more effective cross-linking can only be 
beneficial in potentially limiting the adverse side effects of 
glutaraldehyde used, such as calcification or cytotoxicity 
(not discussed here). We recognize, however, that further 
calcification studies are required to fully confirm this 
hypothesis. 
We do not exclude the possible advantage of combining 
such a technique (i.e., dynamic fixation) with anticalcifi- 
cation treatments to optimally reduce the risks of long- 
term calcification of bioprosthetic tissue. 
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Use of aprotinin after cardiac operations 
To the Editor: 
The article by ~i~ek and colleagues 1 on the postopera- 
tive use of aprotinin (Trasylol) to reduce blood loss after 
